Geron Presents Interim Clinical Data On Its Telomerase Inhibitor Drug Trial In Patients With Multiple Myeloma

Geron Corporation (Nasdaq:GERN) today announced the presentation of interim data at the 2008 meeting of the American Society of Hematology in San Francisco, CA, for its ongoing clinical trial of GRN163L, a telomerase inhibitor drug, in patients with relapsed and refractory multiple myeloma. This study of GRN163L as a single agent is one of six ongoing clinical trials recruiting from 18 U.S.

More: continued here

Filed under: Blood on December 11th, 2008

Comments are closed.

« Democratic Congressional Leaders Express Doubts About Passage Of Financial Assistance Proposal For Automakers Largest Gathering Of Neuromodulation Experts Explores Breaking Developments In Neurodevice Technologies »

Healthy Recipes 4 All - : Healthy Recipes 4 All
My Pills Store - Buy Online: My Pills store
Online RX Pharmacy - Buy Drugs: Online Rx pharmacy
Order Cheap Pills - Buy Drugs: Order Cheap Pills from online pharmacy.
Order RX Drugs - Buy Online: Order RX Drugs from pharmacy online.
RX Pharmacy Online - Buy Drugs: RX Pharmacy online
RX Pills Shop - Buy Drugs: RX pills shop
RX Pills Store - Buy Drugs: RX pills sotre
RX Discount Plus - Buy Drugs: Discount plus - A method that you get extra money even if you take discount products.
Soma Drugs - Soma Pills: Soma is a muscle relaxant used to relieve the pain and stiffness of muscle.
Latest News...